We help determine whether a CNS drug is truly working or driven by placebo effects, enabling earlier, data-driven Go/No-Go decisions.
Integration of diverse neural datasets to create a comprehensive biological profile.
Advanced algorithms specifically trained to distinguish true pharmacological effects from placebo-related neural fluctuations.
Objective measurement of neural activity across all trial sites to mitigate the risk of false-positive interpretations.
Cross-subject and cross-therapy evaluation of response patterns to refine dose selection and study environments.
Identify true neural engagement early and avoid progressing therapies driven by placebo response.
"Detect True Drug Signal"
Make earlier, data-driven Go/No-Go decisions using objective neural signals than subjective endpoints.
"Reduce Placebo Noise"
Prioritize therapies thatshow real biological activity and allocate resources more efficiently.
"Decide Earlier with Confidence"
CNS drug
development relies too heavily on subjective endpoints, making it difficult to know whether a
therapy is truly working.
We believe the future is different. A future where decisions are guided by objective neural signals,
not subjective interpretation.
At Panikcure, we are building towards a simple idea: